Dr. Ramezani, one of the researchers of the plan, said the drug is prescribed for people suffering migraine based on special protocols.
He said that the liquid form of the drug which is absorbed quickly has been produced.
Ramezani said that the drug would enter into the third phase of production after receiving permit from Iranian Food and Drug Organization.
According to Ramezani, the medicine is going to be tested on some hundreds of people in a clinic.
He said that 8.1 percent of people were absolutely treated with the drug, and the number of attacks decreased for the remaining individuals.
... Payvand News - 03/25/16 ... --